Literature DB >> 33619842

An Affinity-Based, Cysteine-Specific ATP Analog for Kinase-Catalyzed Crosslinking.

Ahmed E Fouda1, Aparni K Gamage1, Mary Kay H Pflum1.   

Abstract

Kinases mediate cell signaling pathways by catalyzing protein phosphorylation. Irregularities in kinase activity are directly associated with disease conditions. Therefore, methods to identify substrates of a particular kinase are needed to understand signaling cascades in normal and diseased states. Photocrosslinking ATP analogs provide powerful tools to study kinases by covalently linking kinases with substrates. However, the involvement of UV light and nonspecific reactivity of current ATP-photocrosslinkers challenge kinase-substrate identification. We report here an affinity-based crosslinking ATP analog, ATP-methylacrylamide (ATP-MAc), that contains a cysteine-reactive acrylamide crosslinking group, which avoids the UV irradiation and non-specific reactivity of prior analogs. Using in vitro kinase assays, ATP-MAc acts as a kinase co-substrate and covalently crosslinks only kinases containing cysteines in the active site. ATP-MAc was also able to crosslink cellular proteins in lysates, documenting compatibility with cell-based studies.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  ATP; affinity-based crosslinkers; conjugation; enzyme catalysis; kinases

Mesh:

Substances:

Year:  2021        PMID: 33619842      PMCID: PMC8084585          DOI: 10.1002/anie.202014047

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  32 in total

1.  Development of photo-crosslinking reagents for protein kinase-substrate interactions.

Authors:  Keykavous Parang; Jeffrey A Kohn; S Adrian Saldanha; Philip A Cole
Journal:  FEBS Lett       Date:  2002-06-05       Impact factor: 4.124

2.  A mechanism-based cross-linker for the identification of kinase-substrate pairs.

Authors:  Dustin J Maly; Jasmina A Allen; Kevan M Shokat
Journal:  J Am Chem Soc       Date:  2004-08-04       Impact factor: 15.419

3.  Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates.

Authors:  K Shah; Y Liu; C Deirmengian; K M Shokat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 4.  Developing irreversible inhibitors of the protein kinase cysteinome.

Authors:  Qingsong Liu; Yogesh Sabnis; Zheng Zhao; Tinghu Zhang; Sara J Buhrlage; Lyn H Jones; Nathanael S Gray
Journal:  Chem Biol       Date:  2013-02-21

5.  A specific inhibitor of the epidermal growth factor receptor tyrosine kinase.

Authors:  D W Fry; A J Kraker; A McMichael; L A Ambroso; J M Nelson; W R Leopold; R W Connors; A J Bridges
Journal:  Science       Date:  1994-08-19       Impact factor: 47.728

Review 6.  Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.

Authors:  Edward J Filardo
Journal:  J Steroid Biochem Mol Biol       Date:  2002-02       Impact factor: 4.292

7.  K-CLASP: A Tool to Identify Phosphosite Specific Kinases and Interacting Proteins.

Authors:  Pavithra M Dedigama-Arachchige; Mary Kay H Pflum
Journal:  ACS Chem Biol       Date:  2016-10-17       Impact factor: 5.100

8.  Isolation and identification of inhibitory compounds on TNF-alpha production from Magnolia fargesii.

Authors:  S H Chae; P S Kim; J Y Cho; J S Park; J H Lee; E S Yoo; K U Baik; J S Lee; M H Park
Journal:  Arch Pharm Res       Date:  1998-02       Impact factor: 4.946

9.  Identification of Kinases and Interactors of p53 Using Kinase-Catalyzed Cross-Linking and Immunoprecipitation.

Authors:  Satish Garre; Aparni K Gamage; Todd R Faner; Pavithra Dedigama-Arachchige; Mary Kay H Pflum
Journal:  J Am Chem Soc       Date:  2018-11-13       Impact factor: 15.419

10.  Bio-orthogonal affinity purification of direct kinase substrates.

Authors:  Jasmina J Allen; Scott E Lazerwith; Kevan M Shokat
Journal:  J Am Chem Soc       Date:  2005-04-20       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.